Discussing Prognosis, Preferences, and End-of-Life Care in Advanced Cancer: We Need to Speak

Belinda E Kiely^{1

2

3}, Martin R Stockler^{1

2

4}

Affiliations

¹ National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown NSW, Australia.
² Concord Cancer Centre, Concord Repatriation General Hospital, Concord NSW, Australia.
³ Macarthur Cancer Therapy Centre, Campbelltown NSW, Australia.
⁴ Chris O'Brien Lifehouse, Camperdown NSW, Australia.

Comment

Belinda E Kiely et al. JAMA Oncol. 2019.

. 2019 Jun 1;5(6):788-789.

doi: 10.1001/jamaoncol.2019.0291.

Belinda E Kiely^{1

2

3}, Martin R Stockler^{1

2

4}

¹ National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown NSW, Australia.
² Concord Cancer Centre, Concord Repatriation General Hospital, Concord NSW, Australia.
³ Macarthur Cancer Therapy Centre, Campbelltown NSW, Australia.
⁴ Chris O'Brien Lifehouse, Camperdown NSW, Australia.

No abstract available

Comment on

Evaluating an Intervention to Improve Communication Between Oncology Clinicians and Patients With Life-Limiting Cancer: A Cluster Randomized Clinical Trial of the Serious Illness Care Program.
Paladino J, Bernacki R, Neville BA, Kavanagh J, Miranda SP, Palmor M, Lakin J, Desai M, Lamas D, Sanders JJ, Gass J, Henrich N, Lipsitz S, Fromme E, Gawande AA, Block SD. Paladino J, et al. JAMA Oncol. 2019 Jun 1;5(6):801-809. doi: 10.1001/jamaoncol.2019.0292. JAMA Oncol. 2019. PMID: 30870556 Free PMC article. Clinical Trial.